
Atea Pharmaceuticals, Inc.
AVIRHealthcare|Biotechnology|US
$4.31
+0.09 (+2.13%)
DCF Value
$1.01
Tangible Book / Share
$2.55
Cash / Share
$2.74
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (2)
Dec 2026
Est. completion
Dec 2026
Est. completion
P3HEPATITIS C VIRUS CHRONIC INFECTION
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277n=880
Recent Press Releases
Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026
Nov 2, 2026 · GlobeNewsWire
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 8, 2026 · GlobeNewsWire
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 12, 2026 · GlobeNewsWire
SEC Filings (47)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 6, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Jun 22, 2026 | 8-K | Material event | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| May 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 27, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 5, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 9, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 8, 2026 | 8-K | Material event | DocumentIndex |
| Dec 5, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Aug 7, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Aug 6, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 20, 2025 | 8-K | Material event | DocumentIndex |
| May 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2025 | 8-K | Material event | DocumentIndex |
| Apr 29, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 23, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 17, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Apr 17, 2025 | 8-K | Material event | DocumentIndex |
| Apr 3, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 1, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 1, 2025 | 8-K | Material event | DocumentIndex |
| Mar 26, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2025 | DFAN14A | DocumentIndex | |
| Mar 24, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 24, 2025 | 8-K | Material event | DocumentIndex |
| Mar 21, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 6, 2025 | 10-K | Annual report | DocumentIndex |
| Mar 6, 2025 | 8-K | Material event | DocumentIndex |
| Mar 4, 2025 | SC 13D | Activist / 5%+ stake | DocumentIndex |